69097-740-31 : NDC 2026 Code

69097-740-31 : Dihydroergotamine Mesylate Nasal ( Dihydroergotamine Mesylate Nasal )

Additionally :

You can get information about “69097-740-31” NDC code in 69097-740-31 in HTML format

HTML | 69097-740-31 in TXT (Plain Text) format

TXT | 69097-740-31 in PDF (Portable Document Format)

PDF | 69097-740-31 in XML format

XML formats.

NDC Code : 69097-740-31 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "69097-740-31",
    "PackageDescription": "1 VIAL in 1 KIT (69097-740-31)  &gt; 1 mL in 1 VIAL",
    "NDC11Code": "69097-0740-31",
    "ProductNDC": "69097-740",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Dihydroergotamine Mesylate Nasal",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dihydroergotamine Mesylate Nasal",
    "DosageFormName": "SPRAY, METERED",
    "RouteName": "NASAL",
    "StartMarketingDate": "20201211",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA212907",
    "LabelerName": "Cipla USA Inc.",
    "SubstanceName": "DIHYDROERGOTAMINE MESYLATE",
    "StrengthNumber": "4",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Ergotamine Derivative [EPC], Ergotamines [CS]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2024-01-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20231231",
    "StartMarketingDatePackage": "20201211",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}